{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:39:44Z","timestamp":1792726784346,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cmi.2026.08.023","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:47:46Z","timestamp":1787410066000},"page":"1758-1766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The promise of monoclonal antibody interventions in malaria: a narrative review"],"prefix":"10.1016","volume":"32","author":[{"given":"Mohammed A.","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneth-Mwasi","family":"Tumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omary Zubery","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Ngonyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximillian","family":"Mpina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Tearish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Berens-Riha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.08.023_bib1","series-title":"World malaria report 2023","year":"2023"},{"key":"10.1016\/j.cmi.2026.08.023_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM): An overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2026.08.023_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: A randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.08.023_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12916-024-03604-8","article-title":"A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children","volume":"22","author":"Walker","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12916-018-1054-2","article-title":"Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children","volume":"16","author":"Kurtovic","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-0716-2189-9_23","article-title":"Analysis of antibody reactivity to malaria antigens by microsphere-based multiplex immunoassay","volume":"2470","author":"Walker","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cmi.2026.08.023_bib7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/biom13081267","article-title":"High-throughput antibody profiling identifies targets of protective immunity against P. falciparum Malaria in Thailand","volume":"13","author":"Hassan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.cmi.2026.08.023_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07218","article-title":"Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function","volume":"4","author":"Portugal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.cmi.2026.08.023_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fmicb.2014.00249","article-title":"Malaria drives T cells to exhaustion","volume":"5","author":"Wykes","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2026.08.023_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aap8029","article-title":"Clonal selection drives protective memory B cell responses in controlled human malaria infection","volume":"3","author":"Murugan","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.22207\/JPAM.19.2.35","article-title":"Toll-like receptors in malaria: Gatekeepers of innate immunity and pathogenesis","volume":"19","author":"Abosalif","year":"2025","journal-title":"J Pure Appl Microbiol"},{"issue":"Suppl","key":"10.1016\/j.cmi.2026.08.023_bib12","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1017\/S0031182005008152","article-title":"Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors","volume":"130","author":"Nebl","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.cmi.2026.08.023_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","article-title":"Immunopathogenesis of cerebral malaria","volume":"36","author":"Hunt","year":"2006","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cmi.2026.08.023_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/jit134","article-title":"Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites","volume":"208","author":"Moormann","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: Recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cmi.2026.08.023_bib16","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"Osier","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2026.08.023_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pathogens14010071","article-title":"Targeting T-cell activation for malaria immunotherapy: Scoping review","volume":"14","author":"Gustifante","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2026.08.023_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004894","article-title":"FCRL5 delineates functionally impaired memory B cells associated with Plasmodium falciparum exposure","volume":"11","author":"Sullivan","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.08.023_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","article-title":"Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria","volume":"23","author":"Polley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.08.023_bib20","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/IAI.68.4.1964-1966.2000","article-title":"Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids","volume":"68","author":"Narum","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2026.08.023_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.1996.54.443","article-title":"Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity","volume":"54","author":"Al-Yaman","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2026.08.023_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003557","article-title":"Antibody-mediated growth inhibition of Plasmodium falciparum: Relationship to age and protection from parasitemia in Kenyan children and adults","volume":"3","author":"Dent","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.08.023_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161301","article-title":"High opsonic phagocytosis activity and growth inhibition of merozoites are associated with RON4 antibody levels and protect against febrile malaria in Ghanaian children","volume":"14","author":"Kyei-Baafour","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.799306","article-title":"Plasmodium falciparum-specific memory B-cell and antibody responses are associated with immunity in children living in an endemic area of Kenya","volume":"13","author":"Jahnmatz","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000912","article-title":"The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections","volume":"6","author":"Weiss","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.08.023_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41541-025-01308-5","article-title":"IFN-\u03b3 and IL-4 correlate with protection induced by an attenuated malaria vaccine","volume":"10","author":"Robinson","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cmi.2026.08.023_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000364","article-title":"Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria","volume":"5","author":"Walther","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.08.023_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-2815-6_3","article-title":"Characterization of liver CD8 T cell subsets that are associated with protection against pre-erythrocytic Plasmodium parasites","volume":"1325","author":"Zarling","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cmi.2026.08.023_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imr.13202","article-title":"Memory CD8+ T cell-mediated protection against liver-stage malaria","volume":"316","author":"Hassert","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cmi.2026.08.023_bib31","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1073\/pnas.0805452105","article-title":"Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria","volume":"105","author":"Schmidt","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2026.08.023_bib32","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.169.6.2956","article-title":"Innate immune response to malaria: Rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes","volume":"169","author":"Artavanis-Tsakonas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3424","article-title":"Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection","volume":"20","author":"Liehl","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib34","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3389\/fimmu.2018.03006","article-title":"Parasite recognition and signaling mechanisms in innate immune responses to malaria","volume":"9","author":"Gowda","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/diseases13040123","article-title":"Correlation of inflammatory biomarkers and IgG4 antibodies with malaria in Cameroon\u2019s Buea Municipality Children","volume":"13","author":"Dinga","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.cmi.2026.08.023_bib36","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1128\/IAI.72.10.5630-5637.2004","article-title":"Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls","volume":"72","author":"Lyke","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2026.08.023_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.594621","article-title":"Type I interferons and malaria: A double-edge sword against a complex parasitic disease","volume":"10","author":"He","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2026.08.023_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.it.2009.12.002","article-title":"Regulatory T cells in malaria\u2014friend or foe?","volume":"31","author":"Finney","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib39","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: The master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib40","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","article-title":"Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure","volume":"102","author":"Drakeley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2026.08.023_bib41","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helb","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2026.08.023_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/infdis\/jis675","article-title":"Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration","volume":"207","author":"Hendriksen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib43","doi-asserted-by":"crossref","first-page":"e2415","DOI":"10.1093\/cid\/ciaa1141","article-title":"Plasma Plasmodium falciparum histidine-rich protein 2 concentrations in children with malaria infections of differing severity in Kilifi, Kenya","volume":"73","author":"Uyoga","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib44","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: Secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004877","article-title":"Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial","volume":"23","author":"Hysa","year":"2026","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib46","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4269\/ajtmh.18-0805","article-title":"Antibody correlates of protection from clinical Plasmodium falciparum malaria in an area of low and unstable malaria transmission","volume":"103","author":"Hamre","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2026.08.023_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2026.102756","article-title":"Malaria immunity in the infant: Progress and pitfalls","volume":"100","author":"Feeney","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1821434","article-title":"Transplacental transfer of anti-malarial antibodies: A systematic review","volume":"17","author":"Belete","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634749","article-title":"Malaria and early life immunity: Competence in context","volume":"12","author":"Callaway","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.023_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0031182015001626","article-title":"Plasmodium malaria and antimalarial antibodies in the first year of life","volume":"143","author":"Dobbs","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.cmi.2026.08.023_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.placenta.2023.07.011","article-title":"Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies?","volume":"140","author":"Kayatani","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.cmi.2026.08.023_bib52","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1086\/379373","article-title":"Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection","volume":"188","author":"Kicska","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014798","article-title":"A role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria","volume":"6","author":"Amaratunga","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.08.023_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.cmi.2026.08.023_bib55","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMe2207865","article-title":"Monoclonal antibodies\u2014a different approach to combat malaria","volume":"387","author":"Daily","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib57","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib58","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ymthe.2022.04.001","article-title":"Monoclonal antibodies for malaria prevention","volume":"30","author":"Aleshnick","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.cmi.2026.08.023_bib59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A monoclonal antibody for malaria prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib60","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","article-title":"Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): A phase 1, adaptive trial","volume":"23","author":"Lyke","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib61","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","article-title":"Safety and efficacy of a monoclonal antibody against malaria in Mali","volume":"387","author":"Kayentao","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib62","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1038\/s41591-025-03739-y","article-title":"Anti-sporozoite monoclonal antibody for malaria prevention: Secondary efficacy outcome of a phase 2 randomized trial","volume":"31","author":"Skinner","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib63","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","article-title":"Subcutaneous administration of a monoclonal antibody to prevent malaria","volume":"390","author":"Kayentao","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1473-3099(25)00481-5","article-title":"Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: A first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial","volume":"26","author":"Lyke","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00071-23","article-title":"Vaccines and monoclonal antibodies: New tools for malaria control","volume":"37","author":"Miura","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2026.08.023_bib66","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S1473-3099(22)00428-5","article-title":"Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: A single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults","volume":"22","author":"van der Boor","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.023_bib67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2203067","article-title":"Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.023_bib68","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0140-6736(26)00258-8","article-title":"Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"407","author":"Steinhardt","year":"2026","journal-title":"Lancet"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:18:53Z","timestamp":1792725533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26004726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1198743X26004726"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The promise of monoclonal antibody interventions in malaria: a narrative review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}